The Patent Finder

Terms ending in 2043

Adimab, LLC

Every in-force patent on Adimab, LLC's record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,552,863High Affinity ANTI-CD3 Antibodies, and Methods for Their Generation and Use
In force
 · High confidence
Adimab, LLCIn forceHigh confidence
US 12,790,373CH1 Domain Variants Engineered for Preferential Kappa Light Chain Pairing and Multispecific Antibodies Comprising the Same
In force
 · High confidence
Adimab, LLCIn forceHigh confidence
2 of 2 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited